STOCK TITAN

Irenic Acquisition (IACQ) 10-Q Filings

IACQ NASDAQ

Here are the 10-Q quarterly reports from Irenic Acquisition Corp. (IACQ) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow IACQ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IACQ filings page.

Rhea-AI Summary

Irenic Acquisition Corp. (IACQ) reported net income of $2,093,733 for the three months ended September 30, 2026, from $2,346,195 of interest earned on Trust Account investments, offset by $252,462 of general and administrative costs. The company had not begun operations or generated operating revenue as of September 30. At quarter-end, it held $256,406,059 in the Trust Account, with $983,528 in cash and working capital of $828,826.

The blank-check company is identifying a business-combination target and has 24 months from the April 29, 2026 IPO closing to complete a transaction, subject to any amended period. Under a forward purchase agreement, Irenic Capital Evergreen Master Fund LP agreed, subject to conditions including its investment committee’s approval before Irenic enters a definitive business-combination agreement, to buy 5,000,000 units for $10.00 each, or $50,000,000 in total. The purchase is expected to close with the business combination. Public shareholders may redeem all or part of their shares in connection with a business combination.

Rhea-AI Summary

Irenic Acquisition Corp., a Cayman Islands special purpose acquisition company, reported net income of $1.37 million for the quarter ended June 30, 2026, driven mainly by $1.53 million of interest on marketable securities held in its trust account, partially offset by $171,066 of general and administrative expenses. Since inception on March 4, 2026 through June 30, 2026, cumulative net income was $1.31 million.

Total assets were $255.35 million, including $254.06 million of marketable securities in the Trust Account and $1.02 million of cash outside the trust, with working capital of $1.05 million. Following its IPO and partial over-allotment exercise, the company sold 25,253,188 units at $10.00 per unit, placing $252.53 million in the Trust Account, and incurred $15.80 million in offering transaction costs, including $10.10 million of deferred underwriting fees. As of June 30, 2026, 25,253,188 Class A shares were classified as subject to possible redemption at $10.06 per share.

The SPAC has 24 months from the April 29, 2026 IPO closing (the “Completion Window”) to complete an initial business combination, and also has a $50 million forward purchase commitment for 5,000,000 forward purchase units, subject to the investor’s committee approval. Management states it has sufficient liquidity for at least one year, but discloses a material weakness in internal control over financial reporting related to the financial statement review process, concluding disclosure controls and procedures were not effective as of June 30, 2026.